期刊文献+

获得性免疫缺陷综合征并发巨细胞病毒性视网膜炎的药物治疗现状和进展 被引量:5

Present status and advances in pharmacotherapy for cytomegalovirus retinitis associated with acquired immunodeficiency syndrome
原文传递
导出
摘要 巨细胞病毒性视网膜炎是获得性免疫缺陷综合征晚期最常见、最严重的眼部机会性感染,是导致患者视力丧失的最主要原因.继更昔洛韦、膦甲酸在临床广泛应用后,缬更昔洛韦、西多福韦及福米韦生也已经获得美国药品与食品管理局批准,先后应用于眼科临床,取得了一定的治疗效果.目前,马立巴韦、MSL-109单克隆抗体、Cyclopropavir及BAY 38-4766 正在进行Ⅰ期、Ⅱ期或Ⅲ期临床试验,可望给临床治疗带来新的希望. Cytomegalovirus retinitis has been the most common opportunistic infection and leading cause of visual loss in AIDS patients. There are five drugs approved by the Food and Drug Administration in the USA for the treatment of cytomegalovirus retinitis: ganeiclovir, foscarnet/phosphonoformic acid,valganciclovir, eidofovir and formivirsen. Progress has been made in the treatment of cytomegalovirus retinitis. Nowadays, maribavir, monoclonal antibody MSL-109, cyclopropavir and BAY 38-4766 are entering clinical trials. This review summarizes present status and advances in pharmacotherapy for cytomegalovirus retinitis in AIDS.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2010年第12期1148-1152,共5页 Chinese Journal of Ophthalmology
关键词 巨细胞病毒视网膜炎 获得性免疫缺陷综合征 药物疗法 Cytomegalovirus retinitis Acquired immunodeficiency syndrome Drug therapy
  • 相关文献

参考文献43

  • 1Holland GN.AIDS and ophthalmology:the first quarter century.Am J Ophthalmol,2008,145:397-408.
  • 2Wiegand TW,Young LH.Cytomegalovirus retinitis.Int Ophthalmol Clin,2006,46:91-110.
  • 3Jabs DA.AIDS and ophthalmology 2008.Arch Ophthalmol,2008,126:1143-1146.
  • 4Jabs DA,Martin BK,Ricks MO,et al.Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.Arch Ophthalmol,1996,114:821-827.
  • 5Lee SS,Hughes PM,Robinson MR.Recent advances in drug delivery systems for treating ocular complications of systemic diseases.Curr Opin Ophthalmol,2009,20:511-519.
  • 6Venkatesh KK,Biswas J,Kumarasamy N.Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.Indian J Ophthalmol,2008,56:391-393.
  • 7Burd EM,Pulido JS,Puro DG,et al.Maintenance of rep1icative intermediates in ganciclovir-treated human cytomegalovirusinfected retinal glia.Arch Ophthalmol,1996,114:856-861.
  • 8Biron KK.Antiviral drugs for cytomegalovirus diseases.Antiviral Res,2006,71:154-163.
  • 9Jabs DA,Enger C,Bartlett JG.Cytomegalovirus retinitis and acquired immunodeficiency syndrome.Arch Ophthalmol,1989,107:75-80.
  • 10叶俊杰,李海燕,孙鼎,闵寒毅,韩宝玲,胡天圣.获得性免疫缺陷综合征并发巨细胞病毒性视网膜炎的临床分析[J].中华眼科杂志,2005,41(9):803-806. 被引量:29

二级参考文献10

  • 1Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol,2004,49:131-157.
  • 2Davis JL. Differential diagnosis of CMV retinitis. Ocul Immunol Inflamm,1999,7:159-166.
  • 3Skiest DJ,Chiller T,Chiller K,et al. Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis. Int J STD AIDS,2001,12:659-664.
  • 4Reed JB,Briggs JW,Mcdonald JC,et al. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis. Retina,2001,21: 339-343.
  • 5Castro KG,Ward JW,Slutsker L,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR,1992,41:RR-17.
  • 6Hoover DR,Peng X. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol,1996,114:821-827.
  • 7赵家良.获得性免疫缺陷综合征眼底改变[A].张承芬主编.眼底病学[C].北京:人民卫生出版社,1998.662-673.
  • 8Callant JE,More RD,Richman DD,et al. Incidence and natural history of cytomegalovirus disease in patients with zidovudine: the zidovudine study group. Infect Dis,1992,166:1223-1227.
  • 9Holland GN. Survival od patients with the acquired immunodeficiency syndrome after development of CMV retinopathy. Ophthalmology,1990,97:204-210.
  • 10李太生,邱志峰,王爱霞,马小军,刘正印,盛瑞媛.T淋巴细胞激活亚群在HIV感染中的变化及其临床意义[J].中华传染病杂志,2002,20(4):199-202. 被引量:32

共引文献28

同被引文献46

  • 1陈之昭,张梅.获得性免疫缺陷综合征的眼部表现[J].中华眼科杂志,2005,41(6):563-571. 被引量:39
  • 2叶俊杰,李海燕,孙鼎,闵寒毅,韩宝玲,胡天圣.获得性免疫缺陷综合征并发巨细胞病毒性视网膜炎的临床分析[J].中华眼科杂志,2005,41(9):803-806. 被引量:29
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 4Kestelyn P.The epidemiology of CMV retinitis in Africa[J].Ocul Immunol Infamm,1999,7(3/4) -173 -7.
  • 5Biswas PN,Saha B,Ghosh S,et al.Ophthalmic manifestations in people living with HIV attending a tertiary care centre of Eastern In-dia[J].J Indian Med Assoc,2008,106(5):292-4.
  • 6Patil A,Sharmal A,Kenney MC,et al.Valganciclovir in the treat-ment of cytomegalovirus retinitis in HIV-infected patients[J].Clini-cal Ophthalmology,2010,4(4):111-9.
  • 7Brantsaeter AB,Holberg-Petersen M,Jeansson S,et al.CMV quan-titative PCR in the diagnosis of CMV disease in patients with HIV-infection-a retrospective autopsy based study[J].BMC Infectious Diseases,2007,6(7).127.
  • 8MW Stewart.Optimal management of cytomegalovirus retinitis in pa-tients with AIDS[J].Clinical Ophthalmology,2010,26(4):285 -96.
  • 9Cvetkovic RS,Wellington K.Valganciclovir:a review of its use in the management of CMV infection and disease in immunocompro-mised patients[J].Drugs,2005,65(6):859 -78.
  • 10Patil AJ,Sharmal A.Kenney MC,et al.valganciclovir in the treat-ment of cytomegalovirus retinitis in HIV-infected patients[J].Clini-cal Ophthalmology,2010,4(4):111 -9.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部